Ehrlich Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Ehrlich Financial Group's XBI Position: Q3 2026 in Review
Ehrlich Financial Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 4,391 shares worth $692K. The stake represents 0.36% of the portfolio and ranks #58 among its holdings.
858 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Ehrlich Financial Group held 4,391 shares of State Street SPDR S&P Biotech ETF worth $692K as of Q3 2026.
- State Street SPDR S&P Biotech ETF was a new Ehrlich Financial Group position in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.36% of Ehrlich Financial Group's portfolio in Q3 2026, its #58 holding.
- 858 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Ehrlich Financial Group's 13F filing for Q3 2026, filed 20 Oct 2026.